Study of a PET imaging agent in healthy people and people with cancer
Part of Cancer clinical trials.
This study uses a special imaging agent (a radioactive tracer) to see how it works in healthy volunteers and in people with cancer. It may help doctors better understand how cancer behaves and how to target it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer (any type, confirmed by a scan or biopsy) and have not had any cancer treatment yet, or your cancer has gotten worse on standard treatment.
- You have at least one tumor that is at least 1.5 centimeters (about the size of a pea).
- You are not currently on cancer treatment (including between cycles).
- You do not have certain heart rhythm problems or risk factors for them (like heart failure, low potassium, or family history of Long QT Syndrome).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new radioactive tracer called 68Ga-SFB6-ZN01 for PET/CT scans in people with suspected or confirmed solid tumors. It aims to see if this tracer can help find cancer or detect recurrence after treatment.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This Phase 1 study tests how safe RAD301 is and how it behaves in the body when given for PET imaging in healthy volunteers and people with certain cancers. It may help doctors learn whether this imaging drug can clearly show cancer areas and be tolerated well.
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.